Centro de Imagem Diagnósticos S.A

AALR3 · SA · Healthcare / Diagnostics & Research

1.31BRL-0.30 (-18.63%)

Price History

Full chart

Market Stats

Previous Close1.61

Open1.70

Day Range1.31 – 1.70

52-Week Range2.36 – 6.66

Volume83.30K

Market Cap517.89M

P/E (TTM)0.00

Forward P/E0.00

EPS-8.93

Dividend Yield0.00%

Beta0.42

50-Day Avg3.24

200-Day Avg3.66

About

Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood count, cholesterol, triglycerides, urinalysis 1, stool test, detection of sexually transmitted diseases, and anatomical pathology; and diagnostic imaging services, such as magnetic resonance, computed tomography, ultrasound, x-rays, bone densitometry, mammography, scintigraphy, and PET-CT (positron emission tomography " computed tomography). It also offers graphic methods examinations, including electrocardiogram, cardiotocography, Holter, ergometric tests, and cardiopulmonary tests. Alliança Saúde e Participações S.A. was formerly known as Centro de Imagem Diagnósticos S.A. and changed its name to Alliança Saúde e Participações S.A. in April 2023. Alliança Saúde e Participações S.A. was founded in 1992 and is based in São Paulo, Brazil.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEOMr. Jose Luiz Mendes Ramos Jr.
Employees5.80K
HeadquartersStreet Afonso de Freitas, 59 - Paraíso, São Paulo, SP, Brazil, 04006-050, Brazil
Websitehttps://www.allianca.com

Leadership

Mr. Jose Luiz Mendes Ramos Jr.Chief Legal & Compliance Officer, Investor Relations Officer and Member of Executive Board
Mr. Weber Franco de MoraisChief Operating officer
Ms. Luci Mara Barbosa Gama BarbieroChief Medical officer

Financials

Income Statement

Currency: BRL	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	55.91M	141.25M	184.19M	275.90M	393.15M	699.66M	951.47M	1.08B	1.08B	1.07B	928.79M	1.14B	1.09B	1.18B	1.22B	1.15B
Growth (%)	-	+152.61%	+30.40%	+49.79%	+42.50%	+77.96%	+35.99%	+13.29%	-0.09%	-0.38%	-13.43%	+22.37%	-4.54%	+8.72%	+3.17%	-5.19%
Cost of Revenue	23.67M	69.92M	87.17M	166.04M	259.65M	422.18M	591.02M	756.58M	787.54M	788.05M	763.47M	780.53M	759.26M	814.78M	861.34M	922.99M
Gross Profit	-	-	97.02M	109.86M	133.50M	277.48M	360.45M	321.30M	289.38M	284.82M	165.32M	356.04M	325.75M	364.80M	355.66M	230.84M
Gross Margin	-	-	52.68%	39.82%	33.96%	39.66%	37.88%	29.81%	26.87%	26.55%	17.80%	31.33%	30.02%	30.93%	29.22%	20.01%
Operating Expense	-	-	64.76M	79.73M	103.71M	168.75M	259.84M	250.96M	152.09M	159.42M	186.71M	273.82M	357.79M	325.90M	248.60M	283.81M
Operating Income	10.39M	33.03M	32.26M	30.13M	29.79M	108.74M	100.61M	70.34M	137.29M	125.39M	-21.38M	82.22M	-32.04M	38.90M	107.06M	-52.97M
Operating Margin	18.58%	23.38%	17.52%	10.92%	7.58%	15.54%	10.57%	6.53%	12.75%	11.69%	-2.30%	7.23%	-2.95%	3.30%	8.80%	-4.59%
EBITDA	-	-	45.51M	56.25M	66.37M	89.96M	156.28M	137.07M	203.98M	245.12M	101.67M	206.49M	74.62M	154.73M	184.67M	54.34M
EBITDA Margin	-	-	24.71%	20.39%	16.88%	12.86%	16.43%	12.72%	18.94%	22.85%	10.95%	18.17%	6.88%	13.12%	15.17%	4.71%
Net Income	-	-	28.51M	27.68M	-4.17M	-12.77M	14.79M	6.65M	40.09M	41.30M	-97.42M	-5.63M	-227.81M	-227.88M	-129.12M	-1.37B
Net Income Margin	-	-	15.48%	10.03%	-1.06%	-1.82%	1.55%	0.62%	3.72%	3.85%	-10.49%	-0.49%	-21.00%	-19.32%	-10.61%	-118.94%
Interest Expense	0	0	0	0	35.40M	59.66M	67.36M	77.39M	66.57M	71.66M	64.48M	90.39M	176.33M	247.00M	177.88M	236.55M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	9.00%	8.53%	7.08%	7.18%	6.18%	6.68%	6.94%	7.95%	16.25%	20.94%	14.62%	20.50%

Balance Sheet

Currency: BRL	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	98.87M	322.65M	327.95M	589.44M	1.46B	1.54B	2.17B	2.28B	2.21B	2.40B	2.54B	2.54B	2.62B	2.67B	2.89B	1.78B
Total Liabilities	63.21M	65.51M	93.02M	309.95M	720.51M	803.35M	954.38M	1.01B	909.71M	1.08B	1.32B	1.33B	1.63B	1.73B	1.75B	2.03B
Total Equity	35.66M	255.31M	232.30M	272.68M	735.78M	716.08M	1.17B	1.22B	1.26B	1.28B	1.19B	1.18B	949.70M	917.46M	1.09B	-277.54M
Cash	4.62M	91.66M	59.33M	51.97M	42.21M	21.92M	159.33M	91.60M	73.17M	88.30M	229.09M	127.31M	218.74M	218.59M	114.97M	116.74M
Total Debt	-	-	17.27M	145.92M	330.37M	465.44M	544.59M	599.25M	605.51M	836.84M	1.05B	1.07B	1.34B	1.31B	951.06M	697.17M
Net Debt	-	-	-42.06M	93.95M	288.16M	443.52M	385.26M	507.65M	532.35M	748.54M	816.58M	944.12M	1.12B	1.09B	836.09M	580.42M

Cash Flow

Currency: BRL	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	10.94M	32.99M	39.07M	17.11M	47.69M	98.56M	78.97M	134.19M	161.19M	213.41M	117.86M	149.13M	187.30M	102.30M	-41.02M	102.22M
Investing Cash Flow	-	-	-63.67M	-112.38M	-128.66M	-103.75M	-150.63M	-167.98M	-116.01M	-77.05M	-64.68M	-105.70M	-142.50M	-111.15M	142.41M	219.85M
Financing Cash Flow	3.02M	99.18M	-7.73M	87.91M	71.21M	-15.10M	209.07M	-33.95M	-63.61M	-121.22M	87.60M	-145.21M	46.63M	8.70M	-205.01M	-320.30M
Capital Expenditure	12.59M	21.61M	49.83M	61.40M	125.65M	102.78M	105.62M	149.02M	86.03M	75.30M	66.71M	100.49M	113.01M	91.52M	99.39M	77.86M
Free Cash Flow	-	-	-10.75M	-44.29M	-77.95M	-4.23M	-26.64M	-14.83M	75.16M	138.11M	51.16M	48.63M	74.29M	10.78M	-140.41M	24.36M
Dividends Paid	10.00M	6.54M	9.75M	15.73M	39.03M	-	-	-	4.08M	22.20M	6.35M	2.00M	1.88M	15.02M	-	17.23M
FCF to OCF	-	-	-27.51%	-258.80%	-163.45%	-4.29%	-33.74%	-11.05%	46.63%	64.72%	43.40%	32.61%	39.67%	10.54%	342.28%	23.83%
Dividend Paid to FCF	-	-	-90.65%	-35.51%	-50.07%	-	-	-	5.43%	16.08%	12.41%	4.12%	2.54%	139.28%	-	70.72%

Earnings

Report Date	Mar 23, 2017	May 10, 2017	Aug 9, 2017	Nov 8, 2017	Mar 28, 2018	May 10, 2018	Aug 12, 2018	Nov 13, 2018	Feb 27, 2019	May 13, 2019	Aug 13, 2019	Nov 12, 2019	Mar 17, 2020	May 19, 2020	Aug 20, 2020	Nov 13, 2020	Mar 17, 2021	May 13, 2021	Aug 12, 2021	Nov 11, 2021	Mar 15, 2022	May 16, 2022	Aug 16, 2022
EPS Estimate	0.05	0.10	0.14	0.08	0.01	0.08	0.09	0.10	-	0.11	0.10	0.14	0.08	-0.04	-0.65	-0.05	0.02	0.05	-	-	-	-	-
EPS Actual	0.16	0.08	0.08	0.13	0.36	0.10	0.08	0.13	0.14	0.08	0.13	0.12	0.13	-0.18	-0.72	-0.03	0.11	0.09	0.09	0.04	-0.27	-0.14	-0.11
Surprise	220.00%	-20.00%	-42.86%	62.50%	3500.00%	25.00%	-11.11%	30.00%	-	-27.27%	30.00%	-14.29%	62.50%	-350.00%	-10.77%	40.00%	450.00%	80.00%	-	-	-	-	-
Timing	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market

Key Statistics & Ratios

Market Cap517.89M

Enterprise Value1.13B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.45

Price / Book0.45

EPS-8.93

Book Value-1.82

Revenue (TTM)1.15B

Gross Profit (TTM)239.54M

EBITDA-986.93M

Profit Margin-118.94%

Operating Margin-58.30%

Return on Equity-307.43%

Return on Assets-27.92%

Shares Outstanding152.32M

Shares Float59.25M

Beta0.42

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20201×

0.09Apr 27, 2020

20191×

0.08Apr 25, 2019